 control trial aerosol ribavirin infant mechan ventil sever respiratori syncyti viru infect background antivir agent ribavirin cours respiratori tract diseas infant respiratori syncyti viru infect ribavirin infant sever respiratori syncyti viru diseas mechan ventil method double-blind placebo-control evalu ribavirin mg millilit aerosol form infant mechan ventil respiratori failur document respiratori syncyti viru infect result infant mean SD age month underli diseas infect mean age month normal mean age month infant ribavirin mean durat mechan ventil day day placebo mean length supplement oxygen use day day mean length hospit stay day treatment ribavirin placebo normal infant mean length hospit stay day ribavirin recipi day placebo conclus infant mechan ventil sever respiratori syncyti viru infect treatment aerosol ribavirin durat mechan ventil oxygen treatment hospit stay